Exacerbation of myasthenia gravis after amoxicillin therapy: a case series

Veria Vacchiano1, Piergiorgio Solli2, Ilaria Bartolomei3

  • 1Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy. veriavacchiano@gmail.com.

Abstract

Insights

Patients with myasthenia gravis (MG) may experience worsening symptoms after amoxicillin antibiotics. Close monitoring is advised during treatment to prevent acute relapses and ensure prompt intervention for recovery.

Area of Science:

  • Neurology
  • Pharmacology
  • Infectious Diseases

Background:

  • Myasthenia gravis (MG) exacerbations can be triggered by various medications, including antibiotics.
  • Penicillins are generally considered safe for MG patients, but rare cases of MG worsening have been documented.
  • This study investigates potential links between penicillin-based antibiotics and MG symptom exacerbation.

Purpose of the Study:

  • To report and analyze cases of myasthenia gravis exacerbation following amoxicillin or amoxicillin/clavulanate treatment.
  • To highlight the potential risk of penicillin-based antibiotics in patients with myasthenia gravis.
  • To emphasize the need for vigilant monitoring in MG patients undergoing antibiotic therapy.

Main Methods:

  • Case series reporting on six patients with myasthenia gravis (MG).
  • Patients developed acute symptom worsening after receiving amoxicillin or amoxicillin/clavulanate.
  • Assessment of symptom severity using the Myasthenia Gravis Foundation of America (MGFA) clinical classification.

Main Results:

  • All six patients experienced worsening of MG symptoms within days of antibiotic administration.
  • A significant increase in MGFA clinical classification was observed in all cases.
  • Most patients required adjustments to their MG treatment, including increased dosages or new medications.
  • Full recovery to baseline neurological status was achieved within 1-2 months for all patients.

Conclusions:

  • Amoxicillin and amoxicillin/clavulanate may precipitate acute relapses in patients with myasthenia gravis.
  • Vigilant monitoring for MG symptom exacerbation is crucial in patients prescribed amoxicillin.
  • Early detection and therapeutic intervention can lead to full recovery in affected patients.

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.6K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
119
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.6K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
11.0K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
4.1K